Drug Profile
NBM BMX softgel capsules - NatureWise Biotech & Medicals
Alternative Names: NBM-BMX; NBM-BMX oral softgel capsulesLatest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator NatureWise Biotech & Medicals Corporation
- Class Antidementias; Antineoplastics; Small molecules
- Mechanism of Action HDAC8 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Glioblastoma; Solid tumours
- No development reported Alzheimer's disease
Most Recent Events
- 11 Aug 2023 Phase-I/II clinical trials in Glioblastoma (First-line therapy, Adjunctive treatment) in Taiwan (PO) (NCT06012695)
- 11 Aug 2023 Phase-I/II clinical trials in Solid tumours (Metastatic disease, Monotherapy) in Taiwan (PO) (NCT06012695)
- 04 Jan 2023 US FDA approves IND application for NBM BMX in glioblastoma multiforme (Newly diagnosed)